ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

CDXC ChromaDex Corporation

3.81
0.01 (0.26%)
시간외 거래
최종 업데이트: 06:56:28
15분 지연
기업명 주식 심볼 시장 주식 타입
ChromaDex Corporation CDXC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01 0.26% 3.81 06:56:28
개장가 저가 고가 종가 전일 종가
3.85 3.63 3.89 3.75 3.80
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:32BWChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR),..
25/04/202421:34BWChromaDex Announces Nationwide Launch of Tru Niagen® at The..
24/04/202421:34BWChromaDex to Report First Quarter 2024 Financial Results on..
23/04/202421:32BWChromaDex Announces Inaugural Major Grocery Debut of Tru..
26/03/202421:32BWChromaDex Announces Tru Niagen® is Now Third-Party Verified..
07/03/202406:04BWChromaDex Corporation Reports Fourth Quarter and Fiscal Year..
07/03/202406:02EDGAR2Form 8-K - Current report
07/03/202406:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
24/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202410:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202422:32BWChromaDex to Report Fourth Quarter 2023 Financial Results on..
05/02/202422:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
27/01/202406:08BWChromaDex to Present at the Lytham Partners 2024 Investor..
20/12/202323:04BWChromaDex Supports the US Military with its Industry Leading..
14/12/202306:00EDGAR2Form 8-K - Current report
13/12/202300:30PRNUSNeurohacker Collective and ChromaDex Partner to Optimize..
05/12/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:34BWA Milestone Phase I Randomized, Double-Blind Clinical Trial..
15/11/202322:32BWNewly Published Phase II Clinical Study Demonstrates that..
09/11/202322:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
09/11/202306:02EDGAR2Form 8-K - Current report
09/11/202306:02BWChromaDex Corporation Reports Third Quarter 2023 Financial..
09/11/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:34BWChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg..
31/10/202321:34BWChromaDex to Report Third Quarter 2023 Financial Results on..
26/10/202321:32BWChromaDex and Zesty Paws® Crack the Code on Cellular Health..
02/10/202321:32BWA Milestone Clinical Study Reveals that Elevating..
07/09/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202319:20EDGAR2Form SC 13D/A - General statement of acquisition of..
24/08/202321:32BWPreclinical Study Builds on Growing Body of Evidence..
16/08/202310:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:02EDGAR2Form 8-K - Current report
10/08/202305:02BWChromaDex Corporation Reports Second Quarter 2023 Financial..
10/08/202305:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:34BWChromaDex Launches Tru Niagen® with iHerb, the World’s..
07/08/202321:32BWChromaDex to Participate in Renmark’s Virtual Non-Deal..
02/08/202321:02BWChromaDex to Report Second Quarter 2023 Financial Results on..
18/07/202321:32BWFindings from Published Abstracts Showcase the Importance of..
07/07/202305:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/07/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
16/06/202321:32BWChromaDex, a Global Authority on Nicotinamide Adenine..
30/05/202321:34BWChromaDex to Participate in the LD Micro Invitational XIII
11/05/202321:34BWChromaDex to Present at the Lytham Partners Spring 2023..
11/05/202305:02BWChromaDex Corporation Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock